<?xml version="1.0" encoding="UTF-8"?>
<p>Based on the results from IHC and Western blot analyses, CK-19 and S100A13 were further analyzed by ELISA in non-depleted cyst fluid samples of the extended material of 17 cPTCs and 55 benign cystic lesions as well as reference samples (
 <xref rid="pone.0126472.t004" ref-type="table">Table 4</xref>). We also included vimentin (VIM), which was identified as a down-regulated protein in cPTC by univariate analysis and in the multivariate OPLS model (
 <xref rid="pone.0126472.s006" ref-type="supplementary-material">S4</xref> and 
 <xref rid="pone.0126472.s008" ref-type="supplementary-material">S6</xref> Tables).
</p>
